Trials / Active Not Recruiting
Active Not RecruitingNCT04511416
Preventing Cognitive Decline with Metformin
Preventing Cognitive Decline with Metformin:: the MetMemory Study
- Status
- Active Not Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 242 (actual)
- Sponsor
- Garvan Institute of Medical Research · Academic / Other
- Sex
- All
- Age
- 60 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
A randomised control study of metformin in people with mild cognitive impairment and without diabetes mellitus to determine effects on cognitive decline and neuroimaging over 3 years.
Detailed description
A randomised placebo-control study of metformin in people with mild cognitive impairment and without diabetes mellitus to determine effects on cognitive decline, neuroimaging and biomarkers over 3 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metformin XR, 500-2000mg nocte | Metformin XR, 500-2000mg nocte |
Timeline
- Start date
- 2022-07-15
- Primary completion
- 2027-12-01
- Completion
- 2027-12-01
- First posted
- 2020-08-13
- Last updated
- 2024-10-02
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT04511416. Inclusion in this directory is not an endorsement.